Meth A sarcoma cell

Meth A sarcoma cells, originating from a chemically induced tumor in Balb/c mice, provide a crucial model for understanding tumor biology and the molecular mechanisms driving sarcoma development. A key aspect of Meth A sarcoma cell research involves the study of the transformation-related protein p53, known for its role in tumor suppression. Typically, p53 is highly labile, but its stability is markedly increased in many fibrosarcoma cell lines derived from tumors induced by physical or chemical agents. This stabilization often correlates with the formation of a stable complex with the heat shock protein cognate hsc70. Interestingly, Meth A sarcoma cells exhibit unique behavior regarding p53 stability. Despite p53 being very stable in these cells, there is no detectable interaction with hsc70. This suggests that the inability to form such a complex is likely due to the primary structure of the endogenous p53. When other p53 variants are introduced into Meth A sarcoma cells, a p53-hsc70 complex does form, indicating that the primary structure of p53 is a critical determinant of its interaction with hsc70 and, consequently, its stability. Further investigations using stable transfection experiments have revealed that different p53 variants are degraded at distinct rates in various transformed cell types, emphasizing the role of p53's primary structure in determining its turnover rate. Additionally, the cellular environment also influences p53 stability, as evidenced by differing degradation rates of at least one p53 variant in nontransformed BALB/c-3T3 cells compared to transformed fibrosarcoma cells. This highlights the complex interplay between genetic factors and cellular context in regulating p53 stability and function in Meth A sarcoma cells.

SKU:BHC11100423

• SDS (1EEF4C74411A4EE3ACCB3A13937505A0)
• Product Sheet (1EEF4C74411A4EE3ACCB3A13937505A0)
• Meth A sarcoma 400284-619 Cytion CoA (PDF)
• Meth A sarcoma 400284-190325 Cytion CoA (PDF)
• Meth A sarcoma 400284-619SF Cytion CoA (PDF)

Tumorigenic: Yes

• cultureMedium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
• supplements: Supplement the medium with 10% FBS
• doublingTime: 28 to 30 hours
• subculturing: Allow cell aggregates to settle to the bottom of the flask, discard the supernatant medium, disperse the cells with gentle pipetting and dispense into new flasks. Resuspend cell suspension in the flask and take representative aliquot to count the cell number per ml. Dilute cell suspension to 1x105 cells/ml with fresh medium and transfer into new flasks.
• seedingDensity: Start new cultures using 2 to 3 x 106 cells/ml. Once the cells have recovered from the freezing and thawing process after 1 to 2 passages, adjust the cell density to 1 x 106 cells/ml when splitting the cells.
• fluidRenewal: 2 to 3 times per week
• postThawRecovery: About 53% of the initial cell number was collected after freezing.
• freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.